Skip to main content

Published locations for MDS: No survival benefit with hypomethylating agents bridging therapy before allo-HSCT

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. MDS: No survival benefit with hypomethylating agents bridging therapy before allo-HSCT

User login

  • Reset your password
  • /content/mds-no-survival-benefit-hypomethylating-agents-bridging-therapy-allo-hsct
  • /hematology-oncology/article/239491/myelodysplastic-syndrome/mds-no-survival-benefit-hypomethylating